What this study is
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are:
1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens?
Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
What's being tested
- Decision Support Tool
Intervention · BEHAVIORAL
The COAST decision support tool will be available in two formats: a booklet and a website. It will provide information about advanced breast cancer and the available treatment options. Participants will be guided through questions designed to clarify their goals and preferences, identify support needs, and concerns they may have.
Study details
- Official title
- Communicating Options for Advanced Breast Cancer Support and Treatment (COAST)
- Sponsor
- Weill Medical College of Cornell University
- Conditions
- Breast Cancer Metastatic · Advanced Breast Cancer · Stage 4 Breast Cancer · Stage IV (Metastatic) Breast Cancer
- Enrolling
- 100 people
- Starts
- 2026-06-17
- Est. completion
- 2028-02
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Male or female 18 years and older
- Diagnosis of Stage IV breast cancer
- English, Spanish or Mandarin speaking
You can't join if
- Early breast cancer
- Individuals speaking languages other than English, Spanish, or Mandarin as their primary language
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openContact for every open site
- Zori K Hamilton, MA · Contact646-962-3694zkh4001@med.cornell.edu
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
- Evelyn Taiwo, MD · Principal investigator
RecruitingNewYork-Presbyterian Medical Group Queens
Flushing, New York, United States
- Pooja Murthy, MD · Principal investigator
RecruitingNewYork-Presbyterian David H. Koch Center
New York, New York, United States
- Shoshana Rosenberg, ScD, MPH · Principal investigator
Recruiting
Study team
Sponsor
Weill Medical College of Cornell University
Study ID 25-07029092
Principal investigator
Shoshana Rosenberg, ScD, MPH
Weill Medical College of Cornell University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.